Notable Analyst Rating Changes 06/02: (AFFX) (JNJ) (DV) Upgraded; (GIS) (ES) (SRE) Downgraded
Get Alerts AFFX Hot Sheet
Join SI Premium – FREE
UPGRADES
Baird upgrades Affymetrix (Nasdaq: AFFX) from Neutral to Outperform, increasing their price target from $6 to $11.
First Global boosts Johnson & Johnson (NYSE: JNJ) from Market Perform to Moderate Outperform. Click Here for more color.
BofA Merrill Lynch lifts DeVry (NYSE: DV) from Neutral to Buy, setting a $68 price target.
Standpoint Research ups Microsoft (Nasdaq: MSFT) from Hold to Buy with a $29 price target. Click Here for more color.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES
UBS downgrades General Mills (NYSE: GIS) from Buy to Neutral.
Wedbush lowers EnergySolutions (NYSE: ES) from Outperform to Neutral, cutting its price target from $7.50 to $5.50. Click Here for more color.
JPMorgan lowers Sempra Energy (NYSE: SRE) from Overweight to Neutral, slicing their price target from $63 to $58.
Jefferies reduces AstraZeneca (NYSE: AZN) from Hold to Underperform and cut its price target from 2,900p to 2,600p. Click Here for more color.
For daily real-time Downgrades go to http://www.streetinsider.com/downgrades
NEW COVERAGE
Goldman Sachs initiates Dendreon (Nasdaq: DNDN) with a Buy rating and $50 price target. Click Here for more color.
Leerink Swann begins Regeneron Pharma (Nasdaq: REGN) with an Outperform. Click Here for more color.
Merriman Curhan Ford starts RealD (NYSE: RLD) at Buy and price target range of $29 - $35.
UBS initiates Mechel (NYSE: MTL) with a Buy.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.
Baird upgrades Affymetrix (Nasdaq: AFFX) from Neutral to Outperform, increasing their price target from $6 to $11.
First Global boosts Johnson & Johnson (NYSE: JNJ) from Market Perform to Moderate Outperform. Click Here for more color.
BofA Merrill Lynch lifts DeVry (NYSE: DV) from Neutral to Buy, setting a $68 price target.
Standpoint Research ups Microsoft (Nasdaq: MSFT) from Hold to Buy with a $29 price target. Click Here for more color.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES
UBS downgrades General Mills (NYSE: GIS) from Buy to Neutral.
Wedbush lowers EnergySolutions (NYSE: ES) from Outperform to Neutral, cutting its price target from $7.50 to $5.50. Click Here for more color.
JPMorgan lowers Sempra Energy (NYSE: SRE) from Overweight to Neutral, slicing their price target from $63 to $58.
Jefferies reduces AstraZeneca (NYSE: AZN) from Hold to Underperform and cut its price target from 2,900p to 2,600p. Click Here for more color.
For daily real-time Downgrades go to http://www.streetinsider.com/downgrades
NEW COVERAGE
Goldman Sachs initiates Dendreon (Nasdaq: DNDN) with a Buy rating and $50 price target. Click Here for more color.
Leerink Swann begins Regeneron Pharma (Nasdaq: REGN) with an Outperform. Click Here for more color.
Merriman Curhan Ford starts RealD (NYSE: RLD) at Buy and price target range of $29 - $35.
UBS initiates Mechel (NYSE: MTL) with a Buy.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AZZ, Inc. (AZZ) Announces Proposed 4M Share Offering
- JPMorgan says S&P 500 tactical bounce 'poised to continue'
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
Create E-mail Alert Related Categories
Special ReportsRelated Entities
UBS, JPMorgan, Jefferies & Co, Robert W Baird, Merriman Curhan Ford, Notable Analyst Rating Changes, Standpoint ResearchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!